CMS received an external request to add CPT code 83037—Hemoglobin; glycosylated (A1c) by device cleared by FDA for home use—as a HCPCS code encompassed under the national coverage determination (NCD) on glycated hemoglobin/glycated protein testing at section 190.21 of the Medicare National Coverage Determination Manual (NCDM).
Section 190.21 of the NCDM states that glycated hemoglobin testing is used “to assess long-term glucose control in diabetes.” The NCDM includes alternate names for this testing which include, “glycated or glycosylated hemoglobin or Hgb, hemoglobin glycated or glycosylated protein, and fructosamine.”
We believe that the CPT code 83037—Hemoglobin; glycosylated (A1c) by device cleared by FDA for home use—may flow from this narrative description of the tests for which the policy contained section 190.21 of the NCDM applies.
We seek public comments on the request to add code 83037 to the list of HCPCS codes applicable to the glycated hemoglobin NCD.
The 30-day public comment period begins with this date, and ends after 30 calendar days. CMS considers all public comments, and is particularly interested in clinical studies and other scientific information relevant to the test under consideration.
